Biocon
Biocon Ltd is a major Indian multinational biopharmaceutical enterprise headquartered in Bengaluru, India. The company specializes in the discovery, development, manufacturing, and commercialization of affordable biosimilars, complex small-molecule active pharmaceutical ingredients (APIs), generic formulations, and novel biologic therapeutics targeting oncology, immunology, and diabetes. Principal revenue is derived through commercial pharmaceutical product sales, contract research and manufacturing services (through its subsidiary Syngene), and licensing fees. Biocon Ltd is publicly listed on the National Stock Exchange of India and the BSE.
4 of the funds FundTelligence covers report a position in Biocon.
- Legal name
- Biocon Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 4
Funds holding Biocon
- JPM India Fund — JPM · 0.94 % (full portfolio disclosed, June 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.03 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.02 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)